1. South Korea Stocks

  2. •

    Technology services

  3. •

    Packaged software
GC MediAI Corporation

GC MediAI Corporation

KKRX:032620
2,895.00
KRW
-35.00
(-1.19%)
709.06EPS
5.77P/E
199.83BMarket Cap
GC MediAI Corporation
KRX:032620
(Korea Stock Exchange)

Recent

price

2,895.00

P/E

ratio

5.77

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
1,299.22
1,409.3
1,613.42
1,635.36
1,397.77
1,474.67
1,682.92
2,075.51
2,095.78
2,169
2,067.75
2,199.72
2,640.14
3,059.78
3,725.03
3,897.61
3,984.6
Revenue per Share
65
89.59
25.93
-88
-65
154
125
90
121
133
123
262
71
-34
-31
729
682.1
Basic EPS, GAAP
123.03
83.2
-35.82
-35.17
106.02
159.07
61.09
214.51
154.98
178.24
174.16
121.84
39.58
-0.82
-77.01
110.36
-30.87
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
29.8
30.07
24.54
35.16
40.05
49.94
40.19
60.48
59.5
30.01
- -
Dividend per Share
1,090.53
1,172.31
1,184.66
1,093.65
980.33
1,124.61
1,174.26
1,193.97
1,980.14
2,021.46
2,099.31
2,323.27
2,299.84
2,071.01
1,955.27
2,787.22
2,800.09
Book Value per Share
1,059.35
988.06
858.51
829.7
891.24
1,060.4
1,129.01
1,109.25
1,535.08
1,570.32
1,669.56
1,893.54
1,733.67
1,468.76
1,251.8
1,084.45
1,110.86
Tangible Book Value per Share
40
40
40
40
40
40
41
40
48
51
51
51
51
50
51
51
51
Basic Weighted Avg Shares
52,578
56,776
64,999
65,531
55,763
59,431
68,244
82,091
99,898
110,853
104,804
111,762
133,343
154,041
190,597
197,696
202,230
Sales/Revenue/Turnover
4.35
11.47
0.97
2.93
7.65
7.63
9.29
9.15
9.57
11.14
12.23
8.92
5.66
2.28
2.71
3.92
4.69
Operating Margin (%)
1,138
1,207
1,421
1,411
1,212
1,059
960
881
1,432
2,093
2,347
3,250
3,830
5,385
7,540
8,480
8,765
Depreciation Expense
2,630
3,609
1,045
-3,526
-2,593
6,206
5,069
3,560
5,768
6,797
6,234
13,312
3,586
-1,712
-1,586
36,977
34,618
Net Income, GAAP
3.07
9.25
17.56
435.13
19.74
0.92
29.37
22.46
17.96
31.61
26.52
19.5
28.79
90.05
248.12
3
2.38
Effective Tax Rate (%)
5
6.36
1.61
-5.38
-4.65
10.44
7.43
4.34
5.77
6.13
5.95
11.91
2.69
-1.11
-0.83
18.7
17.12
Profit Margin (%)
23,811
28,955
26,540
25,940
28,376
35,676
34,391
30,583
64,114
68,749
72,203
70,657
50,728
44,166
25,612
29,958
30,171
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
22
8,706
7,778
6,408
3,813
2,490
25,778
26,812
LT Debt
43,933
47,228
46,339
43,844
39,494
45,307
46,556
46,597
104,428
105,875
109,465
121,008
123,507
113,536
107,773
158,889
159,992
Total Equity
5.27
6.7
1.11
-14.21
8.2
10.58
9.65
12.21
10.23
7.99
8.31
6.35
4.13
0.28
-6.25
4.64
5.76
Return on Invested Capital (%)
6.17
7.92
4.29
-6.09
-5.24
14.64
11.04
7.69
7.21
5.96
5.05
10.64
2.53
-1.87
-3.08
23.97
21.99
Return on Capital (%)
6.17
7.92
2.2
-7.68
-6.21
14.64
11.04
7.65
7.78
6.66
5.96
11.86
3.06
-1.54
-1.55
30.72
28.56
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
12,913
6,737
7,543
LT Borrowings
2,731
2,492
3,950
LT Finance Leases
23,799
23,285
22,862
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
205,761
185,361
199,834

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
65,332
65,901
69,117
Cash, Cash Equivalents & STI
29,660
27,610
26,580
Accounts Receivable, Net
17,286
21,093
20,360
Inventories
10,601
9,795
11,521
Total Current Liabilities
36,055
35,943
38,945
Payables & Accruals
- -
- -
- -
ST Debt
12,913
6,737
7,543
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.86%
9.38%
47.43%
Free Cash Flow
916.22%
1,794.75%
-242.06%
Net Income, GAAP
-252.23%
-509.16%
-2,431.2%
Sales/Revenue/Turnover
13.12%
13.78%
3.72%
Total Cash Common Dividend
- -
- -
-50%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
45,499
46,560
46,871
51,667
190,597
2025
45,306
48,674
50,646
53,071
197,696
2026
49,841
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-6
-21
-13
8.3
-31
2025
48
713.02
36.74
-68.97
729
2026
1.44
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
59.5
2025
- -
- -
3.92
-3.92
30.01
2026
- -
- -
- -
- -
- -
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
GC MediAI Corporation is a South Korea-based digital healthcare and medical artificial intelligence (AI) solutions provider that specializes in electronic medical records (EMR), healthcare data analytics, medical equipment distribution, and mobile healthcare platforms. Founded in 1994 and headquartered in Seoul, South Korea, the company operates as a core digital healthcare subsidiary of the GC (Green Cross) Group. The company provides an integrated portfolio of medical information technology products and healthcare solutions, which are categorized into: Electronic Medical Record (EMR) and Practice Management Solutions, comprising its flagship clinic EMR software Ui-sarang and pharmacy management platform E-Pharm, which deliver automated clinical documentation, patient charting, computerized physician order entry, and health insurance claims processing; Medical Equipment and Diagnostic Imaging Systems, covering digital radiography (DR) detectors, diagnostic ultrasound scanners, bone densitometers, and picture archiving and communication systems (PACS) for outpatient clinics and specialized hospitals; Healthcare Market Intelligence and Data Analytics Services, powered by the UBIST analytical platform that aggregates and analyzes nationwide outpatient prescription data, epidemiological statistics, and pharmaceutical sales metrics for pharmaceutical companies and research institutions; and Mobile Healthcare and Patient Engagement Platforms, led by the Ttaktoc application operated through its subsidiary BBROS Co., Ltd., which offers mobile appointment booking, real-time clinic waiting status notifications, contactless check-in, electronic prescription routing, and mobile medical payment services. Additionally, the company operates Pharm-Street, a dedicated business-to-business (B2B) electronic commerce marketplace for pharmaceuticals, medical consumables, and drugstore supplies. In recent operational developments, the company has expanded its strategic focus toward artificial intelligence integration and cloud computing by forming strategic alliances with medical AI developers to incorporate computer-aided diagnostic algorithms, automated voice-recognition charting, and clinical decision support systems (CDSS) into its installed EMR network. Furthermore, the company has rolled out next-generation cloud-native EMR architectures, introduced subscription-based premium patient service models on its mobile platform, and enhanced its connected device ecosystem to support remote monitoring and chronic disease management across primary care networks.